OPEN END TURBO OPTIONSSCHEIN SHORT - COOPER COMPANIES Stock

Certificat

DE000GG8NL50

Market Closed - BOERSE MUENCHEN 02:26:59 2024-07-05 pm EDT
0.119 EUR -0.83% Intraday chart for OPEN END TURBO OPTIONSSCHEIN SHORT - COOPER COMPANIES
Current month+15.53%
1 month+190.24%
Date Price Change
24-07-05 0.119 -0.83%
24-07-03 0.12 +8.11%
24-07-01 0.111 +7.77%
24-06-28 0.103 -0.96%
24-06-27 0.104 +9.47%

Real-time BOERSE MUENCHEN

Last update July 05, 2024 at 02:26 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying THE COOPER COMPANIES, INC.
Issuer Goldman Sachs
WKN GG8NL5
ISINDE000GG8NL50
Date issued 2024-05-24
Strike 98.06 $
Maturity Unlimited
Parity 100 : 1
Emission price 0.04
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.122
Lowest since issue 0.036

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
85.9 USD
Average target price
109.7 USD
Spread / Average Target
+27.73%
Consensus